Search or ask a question

Do cats with multicentric or mediastinal lymphoma have the worst prognosis?

Feline Lymphoma

Best insight from top research papers

Cats with multicentric lymphoma have a variable prognosis, with survival times ranging from months to years depending on the subtype. Intestinal T-cell lymphoma and T-cell-rich B-cell lymphoma have shown promising survival times in cats . On the other hand, cats with mediastinal lymphoma have a shorter median survival time, ranging from 5.4 months to 6.1 months . However, it is important to note that there are variations within each subtype, and individual cases may have different outcomes. Other factors such as treatment options and response to therapy can also influence the prognosis.

Answers from top 5 papers

PDF

Open Access

More filters

Papers (5)	Insight
Journal Article•DOI Distribution of feline lymphoma in the central and peripheral nervous systems Maria Teresa Mandara, Luca Motta, Pietro Calò - Show less +2 more 01 Oct 2016-Veterinary Journal 30 Citations	The paper does not provide information on the prognosis of cats with multicentric or mediastinal lymphoma.
Open access•Journal Article•DOI Prognostic Analyses on Anatomical and Morphological Classification of Feline Lymphoma Hirofumi Sato, Yasuhito Fujino, Junko Chino, Masashi Takahashi, Kenjiro Fukushima, Yuko Goto-Koshino, Kazuyuki Uchida, Koichi Ohno, Hajime Tsujimoto - Show less +8 more 10 Feb 2014-Journal of Veterinary Medical Science 36 Citations	Cats with alimentary lymphoma have a significantly shorter survival compared to cats with mediastinal and nasal lymphomas.
Journal Article•DOI Does categorisation of lymphoma subtypes according to the World Health Organization classification predict clinical outcome in cats Birgitt Wolfesberger, Ondrej Skor, Sabine E. Hammer, Irene Flickinger, Miriam Kleiter, Barbara C. Rütgen, Ilse Schwendenwein, Alexander Tichy, Katharina M. Hittmair, Brigitte Degasperi, Andrea Fuchs-Baumgartinger - Show less +10 more 01 Aug 2017-Journal of Feline Medicine and Surgery 17 Citations	The text does not provide information about the prognosis of cats with multicentric or mediastinal lymphoma.
Open access•Journal Article•DOI Linfoma multicêntrico canino: uma sinopse sobre os aspectos clinicopatológicos e alterações laboratoriais Mariana Ramos Andrade Beraldo, Fernanda L. S. B. Varzim, Lidia Hildebrand Pulz - Show less +2 more 03 Aug 2020 1 Citations	The text does not provide information about the prognosis of cats with multicentric or mediastinal lymphoma.
Open access•Journal Article•DOI Pathohistological features of mediastinal lymphoma in domestic cats K. Oriekhova, O. Shchebentovska - Show less +1 more 03 Aug 2022-Regulatory mechanisms in biosystems 1 Citations	The paper does not specifically mention the prognosis of cats with multicentric or mediastinal lymphoma.

My columns

Related Questions

Which are common heart diseases in cats?5 answersHypertrophic cardiomyopathy (HCM) is the most common heart disease in cats. Other common heart diseases in cats include congestive heart failure (CHF), aortic thromboembolism (ATE), and arrhythmias.

What are the limitations of CAR T cell therapy in lymphoma?4 answersCAR T cell therapy has limitations in the treatment of lymphoma. One limitation is drug resistance, as some individuals are resistant to the therapy due to the immunosuppressive microenvironment of tumors and antigen escape. Another limitation is the occurrence of major adverse effects, including cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS), which can be life-threatening. Additionally, CAR T cell therapy is expensive, making it inaccessible for many patients and raising ethical concerns. In older patients with diffuse large B-cell lymphoma (DLBCL), the use of CAR T cell therapy is limited, and those aged 75 and above have lower event-free survival rates, highlighting the need for more accessible and effective therapies for this age group. Furthermore, CAR T cell therapy faces challenges such as cytokine-related toxicities, on-target off-tumor effects, inferior CAR T cell trafficking, and immunosuppressive tumor microenvironment.

What is the most prevalent form of lymphoma in feline cats?5 answersThe most prevalent form of lymphoma in feline cats is the gastrointestinal form, followed by the multicentric, mediastinal, and extranodal forms.

What is the most common form of lymphoma in feline cats?5 answersGastrointestinal lymphoma is the most common form of lymphoma in feline cats.

What is the most common form of lymphoma in feline with felv?5 answersThe most common form of lymphoma in cats with feline leukemia virus (FeLV) is mediastinal lymphoma.

What prognosis in cats with lymphoma?5 answersThe prognosis for cats with lymphoma varies depending on the type and grade of the lymphoma. Cats with extranodal lymphoma, particularly the renal form, have a cautious prognosis with a high mortality rate. In feline gastrointestinal (GI) lymphoma, serum amyloid A (SAA) concentration on day 56 is a poor prognostic factor for high-grade lymphoma. Cats with high-grade lymphoma and a low lymphocyte to monocyte ratio (LMR) have reduced time to progression (TTP) and overall survival (OS). Feline large granular lymphocyte (LGL) lymphoma has a grave prognosis with a median survival time (MST) of 21 days, although a small subset of cats may survive longer. For nasal lymphoma, there is no significant difference in prognosis between palliative hypofractionated radiotherapy, chemotherapy, or a combination of both.

See what other people are reading

How effective is rituximab in managing the symptoms of Evans syndrome compared to other available treatments?

Rituximab has shown effectiveness in managing Evans syndrome symptoms compared to other available treatments. Evans syndrome, characterized by autoimmune hemolytic anemia, immune thrombocytopenia, and sometimes immune neutropenia, is often treated with corticosteroids, intravenous immunoglobulins, rituximab, and splenectomy for refractory cases. Rituximab, a monoclonal antibody, is commonly used as a second-line treatment for Evans syndrome, especially in cases where patients are unresponsive to steroids. Studies suggest that rituximab, along with corticosteroids and IVIG, can lead to a slow but significant improvement in anemia and thrombocytopenia in Evans syndrome patients. Despite continuous advancements in treatment options, the management of Evans syndrome remains challenging due to its rarity and the need for further improvements in patient outcomes.What are the potential side effects and limitations of current cancer inhibition techniques?

Current cancer inhibition techniques, such as immunotherapy by checkpoint inhibition, have shown efficacy in various malignancies but come with limitations and potential side effects. Side effects of anti-cancer drugs include nephrogenic diabetes insipidus, thrombosis, protein-loss enteritis, heart failure, lactic acidosis, and severe diarrhea. Immunotherapy with immune checkpoint inhibitors can lead to toxicities and resistance, restricting effective responses in some patients. Additionally, there is a need for better biomarkers to identify patients who will benefit from checkpoint inhibition treatment. Combining locoregional therapies with immune checkpoint inhibitors is a promising approach to enhance therapeutic capabilities in oncology, but further research is required to optimize treatment strategies and minimize unnecessary side effects.Β-Amyloid Peptide what was evolutionary purpose?

The β-amyloid peptide (Aβ) is proposed to have an evolutionary purpose as an antimicrobial peptide (AMP) in innate immune defense. Aβ's role as an AMP involves fibrillation to protect against various infectious agents, with evidence suggesting that Aβ oligomers possess potent antimicrobial properties by entrapping pathogens and disrupting cell membranes. The peptide's ancestral function may have been in cell competition mechanisms, subsequently co-opted for neural circuit development and plasticity regulation during evolution. However, with age, factors like reduced natural selection pressure and increased pathogen exposure lead to chronic Aβ induction beyond optimal levels, contributing to Alzheimer's disease pathology. Understanding Aβ's dual role as an AMP and its implications in disease progression could guide future therapeutic strategies for Alzheimer's disease.How does the immune system work?

The immune system is a complex network of cells, organs, and molecules that work together to protect the body from pathogens and maintain overall health. It consists of lymphoid and reticuloendothelial components, with lymphocytes and plasma cells providing specific immunity, while phagocytic cells and plasma cells offer non-specific immunity. This system can adapt to external conditions and is divided into the innate and acquired immune systems, capable of recognizing and destroying harmful pathogens or defective cells. The immune response involves various cells, chemicals like cytokines and chemokines, and organs like the Human Leucocyte Antigen (HLA) to combat foreign invaders effectively. Additionally, the immune system and the nervous system are functionally related, sharing mediators and communication pathways, although they differ in anatomical structure and response mechanisms.Is there computational simulation that can model the evolution of species in biology?

Yes, computational simulations exist to model the evolution of species in biology. These simulations are crucial for generating biomolecular data with known histories, validating phylogenetic inference, and testing evolutionary hypotheses. One such simulator, DomArchov, employs a stochastic model of domain architecture evolution to simulate evolutionary trajectories reflecting constraints observed in nature, such as domain order and co-occurrence. Furthermore, the study of evolution, facilitated by computational tools, focuses on sequence variation detected through DNA or protein sequence comparisons, aiding in phylogenetics and evolutionary dating. These simulations expand the understanding of evolutionary processes, enabling researchers to study a wide range of evolutionary phenomena in various taxonomic and protein function contexts.What is the function of p17 matrix proteins in retrovirus?

The p17 matrix protein in retroviruses, particularly HIV-1, serves multiple functions. It has been identified to have proangiogenic capabilities through molecular mimicry with human erythropoietin, promoting angiogenesis via beta chain receptor activation. Additionally, p17 can cross the blood-brain barrier, potentially contributing to neuronal dysfunction in HIV-1-associated neurocognitive disorder (HAND). Studies have also linked p17 expression to lymphoma development in AIDS patients, suggesting a role in promoting higher microvascular density in tumor tissues. Furthermore, p17 interacts with leukocyte heparan sulfate proteoglycans and chemokine receptors, inducing cytokine-like activities that contribute to AIDS pathogenesis. Notably, p17 is released extracellularly even during HIV-1 latency, with its secretion facilitated by interactions with cellular components at the plasma membrane.What is the best way to euthanize rats to remove the lymph nodes?

The most effective method for euthanizing rats to remove lymph nodes involves considering various factors. Studies have shown that survival surgery under anesthesia is necessary for the removal of lymphoid tissues like the thymus and spleen in rats. Additionally, research on thermal effects on lymph nodes in rats suggests that heat exposure can impact lymph node integrity, highlighting the importance of controlled conditions during euthanasia procedures. Furthermore, experiments involving the transplantation of autologous lymph nodes in rats emphasize the significance of surgical techniques to prevent complications and ensure successful outcomes, indicating the need for precise and careful procedures when handling lymph nodes in rats. Therefore, a combination of proper anesthesia, controlled euthanasia methods, and meticulous surgical techniques is crucial for effectively removing lymph nodes in rats.Flowcytomtery charts of hematologic disease?

Flow cytometry charts of hematologic diseases serve as crucial diagnostic and prognostic tools by providing detailed immunophenotypic profiles of cells. These charts are instrumental in identifying and classifying various hematologic malignancies, including lymphomas, leukemias, and myelodysplastic syndromes (MDS), by analyzing cell surface proteins and other characteristics. The process involves the use of fluorescently labeled antibodies that bind to specific cell markers, allowing for the identification of abnormal cell populations indicative of diseases such as acute lymphoblastic leukemia, chronic lymphocytic leukemia, and others. Moreover, flow cytometry charts are pivotal in the assessment of Minimal Residual Disease (MRD), which is a key factor in determining the efficacy of treatment and guiding therapeutic decisions in hematologic malignancies. This is achieved through multiparametric flow cytometry (MFC), which can detect tumor-associated immunophenotypic profiles with high sensitivity. Recent advancements in technology and analytical software have further enhanced the capabilities of flow cytometry, enabling the analysis of high-dimensional data sets and the application of artificial intelligence for more precise and efficient diagnosis. Additionally, optical genome mapping (OGM) has emerged as a complementary technique, offering a comprehensive view of structural variations in the genome, which is beneficial for a more detailed understanding of hematologic diseases. In clinical settings, automated pipelines for the diagnosis of B-cell malignancies using flow cytometry data have shown promising results, potentially improving turnaround times and reducing workloads. Mass cytometry, another advanced technique, allows for the simultaneous characterization of over 40 parameters per cell, offering deeper insights into disease mechanisms and therapeutic responses. Overall, flow cytometry charts, enriched by these technological advancements, play a vital role in the diagnosis, classification, and management of hematologic diseases, facilitating personalized treatment approaches and improving patient outcomes.What are the axon sizes in dorsal roots?

The sizes of axons in dorsal roots vary significantly across different studies, species, and developmental stages, reflecting a complex interplay of biological factors. In rats, the mean areas of myelinated and unmyelinated fibers in dorsal roots were measured as 13.72 μm² and 0.14 μm², respectively, indicating that both myelinated and unmyelinated central processes of dorsal root ganglion cells are smaller than their peripheral counterparts. This size discrepancy is further supported by findings in cats, where calibers of myelinated axons were symmetrical about the ganglion, but nonmedullated axons showed striking differences in size across the ganglion, with a significant decrease in microtubule densities in central processes compared to peripheral ones. In rabbits, the developmental trajectory of axon sizes in dorsal roots shows a significant increase from newborn to adult stages, with the mean axonal diameter and mean myelin thickness in dorsal roots increasing by 380%. This growth pattern contrasts with the age-related changes observed in rats, where the average overall axon diameter in the L4 dorsal spinal root increases in adult animals but decreases in old rats, suggesting senile atrophy. Further complexity in axon size is observed in the context of injury and regeneration. For instance, large-diameter dorsal root (DR) axons in mice showed the ability to elongate through a DR crush site but not a transection site, indicating that axon size may influence regenerative capacity. Additionally, electron microscopy studies have revealed that the critical diameter for myelination in the peripheral nervous system is about one micron, but in the central nervous system, it is 0.3 μ or less, highlighting a fundamental difference in myelination thresholds between these two systems. Moreover, the ultrastructural characteristics of primary sensory terminals within the spinal cord, which are influenced by axon size, show distinct patterns of degeneration following dorsal root transection, suggesting that axon size may also play a role in the vulnerability to injury and the process of degeneration. The relationship between axon size and conduction velocity, as well as the implications for sensory neuron classification into A and C cells, further underscores the functional significance of axon size in dorsal roots. In summary, axon sizes in dorsal roots are influenced by a multitude of factors including species, age, developmental stage, and pathological conditions, with significant implications for their function, regenerative capacity, and susceptibility to degeneration.What are the advantages of using electronic brachytherapy?

Electronic brachytherapy offers several advantages in cancer treatment. These include reduced radiation exposure to patients and staff due to lower kVp operation, precise delivery of high doses to tumor tissues while sparing healthy surrounding organs, minimal discomfort for patients during treatment sessions, and cost-effectiveness. Additionally, electronic brachytherapy systems like the Axxent Xoft system provide flexibility in treatment locations with minimal radiation shielding requirements. The use of miniaturized X-ray tubes in electronic brachytherapy allows for treatment of various cancers, including skin, brain, breast, spinal metastasis, endometrium, and cervix. Overall, electronic brachytherapy presents a promising alternative to traditional radionuclide-based brachytherapy, offering improved precision, safety, and patient experience in cancer treatment.Is nerve important for tissue regeneration?

Nerves play a crucial role in tissue regeneration. Both in amphibians and mammals, intact nerve innervation is essential for successful tissue repair and regeneration. Nerve-derived signals, Schwann cells, and nerve-derived mesenchymal cells have been identified as key supporters of adult tissue homeostasis and repair. In cases of peripheral nerve injury, nerve tissue engineering strategies, such as artificial nerve substitutes and conduits, have been developed to aid in regeneration. While the peripheral nervous system (PNS) has intrinsic repair abilities, the central nervous system (CNS) in adult mammals faces challenges in self-repair after injury. The influence of nerves on regenerative growth is evident in various systems, with factors like transferrin and growth factors playing potential roles. Therefore, nerves are indeed crucial for tissue regeneration in many contexts.